Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07190300 |
| Title | TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) (TulmiSTAR-02) |
| Acronym | TulmiSTAR-02 |
| Recruitment | Recruiting |
| Gender | male |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Wichita Urology Group PA | RECRUITING | Wichita | Kansas | 67226 | United States | Details |
| Carolina Urologic Research Center | RECRUITING | Myrtle Beach | South Carolina | 29572 | United States | Details |
| Novartis Investigative Site | RECRUITING | Wollongong | New South Wales | 2500 | Australia | Details |
| Novartis Investigative Site | RECRUITING | Hong Kong | 999077 | Hong Kong | Details | |
| Novartis Investigative Site | RECRUITING | Seoul | 05505 | South Korea | Details | |
| Novartis Investigative Site | RECRUITING | Seoul | 06591 | South Korea | Details |